138 related articles for article (PubMed ID: 2124638)
1. [The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects].
Kobayashi Y; Fukuo Y; Shibuya T; Terashi A
Nihon Ronen Igakkai Zasshi; 1990 Sep; 27(5):578-83. PubMed ID: 2124638
[TBL] [Abstract][Full Text] [Related]
2. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
Akanji AO; Abdullah A; Tahzeeb S
Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
[TBL] [Abstract][Full Text] [Related]
4. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.
Glueck CJ; Glueck HI; Tracy T; Speirs J; Stroop D
Metabolism; 1993 Nov; 42(11):1410-9. PubMed ID: 8231835
[TBL] [Abstract][Full Text] [Related]
5. Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus.
Ruiz-Argüelles GJ; Ruiz-Argüelles A; Lobato-Mendizábal E; Díaz-Gomez F; Pacheco-Pantoja E; Drenkard C; Alarcón-Segovia D
Am J Hematol; 1991 May; 37(1):9-13. PubMed ID: 1902623
[TBL] [Abstract][Full Text] [Related]
6. [Relationship of lipoprotein(a) to fibrinolytic activities in healthy subjects].
Xiong X; Zhao S; Wang Z; Lo L; Huang Q
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):555-7. PubMed ID: 10806767
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
[TBL] [Abstract][Full Text] [Related]
8. Activity of tissue plasminogen activator and plasminogen activator inhibitor in noninsulin-dependent diabetes mellitus.
Matsuo T; Kadowaki S; Okada K; Matsuo O
J Diabet Complications; 1990; 4(3):119-21. PubMed ID: 2147433
[TBL] [Abstract][Full Text] [Related]
9. Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease.
Smith FB; Lee AJ; Rumley A; Fowkes FG; Lowe GD
Atherosclerosis; 1995 May; 115(1):35-43. PubMed ID: 7669086
[TBL] [Abstract][Full Text] [Related]
10. Tissue-type plasminogen activator, plasminogen activator inhibitor, and histidine-rich glycoproteins in stressed human newborns.
Corrigan JJ; Jeter MA
Pediatrics; 1992 Jan; 89(1):43-6. PubMed ID: 1728019
[TBL] [Abstract][Full Text] [Related]
11. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
[TBL] [Abstract][Full Text] [Related]
12. Fluctuation of TPA and PAI-1 antigen levels in plasma: difference of their fluctuation patterns between male and female.
Urano T; Sumiyoshi K; Nakamura M; Mori T; Takada Y; Takada A
Thromb Res; 1990 Oct; 60(1):55-62. PubMed ID: 2126149
[TBL] [Abstract][Full Text] [Related]
13. Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects.
Al-Hamodi Z; Ismail IS; Saif-Ali R; Ahmed KA; Muniandy S
Cardiovasc Diabetol; 2011 Mar; 10():23. PubMed ID: 21414238
[TBL] [Abstract][Full Text] [Related]
14. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer.
Glueck CJ; Glueck HI; Tracy T; Speirs J; McCray C; Stroop D
Metabolism; 1993 Feb; 42(2):236-46. PubMed ID: 8474322
[TBL] [Abstract][Full Text] [Related]
15. Association between tissue plasminogen activator and serum lipids in healthy volunteers.
Yamada R; Yamada S; Ishii A; Sasamata M; Watanabe S
Ann Med; 1990; 22(5):313-8. PubMed ID: 2127223
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of a moderately energy-restricted diet on fibrinolytic factors in non-obese men.
Velthuis-te Wierik EJ; Meijer P; Kluft C; van den Berg H
Metabolism; 1995 Dec; 44(12):1548-52. PubMed ID: 8786722
[TBL] [Abstract][Full Text] [Related]
17. Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population.
Sundell IB; Nilsson TK; Hallmans G; Hellsten G; Dahlén GH
Atherosclerosis; 1989 Nov; 80(1):9-16. PubMed ID: 2532510
[TBL] [Abstract][Full Text] [Related]
18. Reduced levels of tissue plasminogen activator and plasminogen activator inhibitor in plasma of patients with familial amyloidotic polyneuropathy.
Olofsson BO; Nilsson TK
Haemostasis; 1990; 20(1):31-6. PubMed ID: 2108913
[TBL] [Abstract][Full Text] [Related]
19. Levels of three hemostatic factors in relation to serum lipids. Monocyte procoagulant activity, tissue plasminogen activator, and type-1 plasminogen activator inhibitor.
Crutchley DJ; McPhee GV; Terris MF; Canossa-Terris MA
Arteriosclerosis; 1989; 9(6):934-9. PubMed ID: 2511826
[TBL] [Abstract][Full Text] [Related]
20. [Plasminogen activator inhibitor and protein C: their relation to plasma lipids and lipo- and apoproteins in ischemic heart disease of different duration].
Zateĭshchikov DA; Gratsianskiĭ NA; Dobrovol'skiĭ AB; Metel'skaia VA; Storozhilova AN; Panchenko EP; Nechaev AS
Kardiologiia; 1990 Apr; 30(4):47-50. PubMed ID: 2395263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
